61%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
61%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
61%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
61%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
DexCom Inc
Closed
Sector Healthcare
88.76 1.15
Overview
Share price change
24h
Min
86.81
Max
88.85
Income | -8.9M 135M |
|---|---|
Sales | -5.8M 994M |
P/E Sector Avg | 41.64 59.526 |
EPS | 0.45 |
Profit margin | 13.539 |
EBITDA | -7.3M 237M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +6.96 upside |
Next Earnings | 13 Feb 2025 |
|---|
Market Cap | 2.2B 33B |
|---|---|
Previous open | 87.61 |
Previous close | 88.76 |
News Sentiment
By Acuity
82%
18%
364 / 392 Healthcare
Technical Score
By Trading Central
Confidence
Strong Bullish Evidence
DexCom Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
DexCom Inc Forecast
Price Target
By TipRanks
6.96% upside
12 Months Forecast
Average 94.93 USD 6.96%
High 115 USD
Low 75 USD
Based on 15 Wall Street analysts offering 12 month price targets forDexCom Inc - Dist in the last 3 months.
Sentiment
By Acuity
364 / 392 Healthcare
News Sentiment
Very Strong Bearish Evidence
Volatility
Below average
News Volume (RCV)
Above average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About DexCom Inc
Dexcom, Inc. is a medical device company. The Company is primarily focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems for use by people with diabetes and by healthcare providers. Its products include Dexcom G6 and Dexcom Share. The G6 is a CGM system that can be used as part of an integrated system with other compatible medical devices and electronic interfaces, which may include automated insulin dosing systems, insulin pumps, blood glucose meters or other electronic devices used for diabetes management. Its Dexcom Share remote monitoring system, offered for use with its Dexcom system, uses an app on the patient’s iPhone, iPod touch, iPad or Android mobile device to securely and wirelessly transmit glucose information to the cloud and then to apps on the mobile devices of up to five designated recipients, who can remotely monitor a patient’s glucose information and receive alert notifications.
